Adenosine A(2A) and group I metabotropic glutamate receptors synergistically modulate the binding characteristics of dopamine D2 receptors in the rat striatum

Neuropharmacology

Volumn 38, Issue 1, 1999, Pages 129-140

  Ferre S ^a   Popoli, P ^b   Rimondini, R ^a   Reggio, R ^b   Kehr, J ^a   Fuxe, K ^a  

^a Div of Cell and Molec Neurochem   (Sweden)

^b Ist Superiore de San 00161 ^*  (Italy)

Author keywords

Adenosine A(2A) receptors; Dopamine D2 receptors; Metabotropic glutamate (mGlu) receptors; Parkinson's disease; Receptor receptor interactions; Striatum

Indexed keywords

1 AMINO 1,5 INDANDICARBOXYLIC ACID; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,5 DIHYDROXYPHENYLGLYCINE; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; CYCLOLEUCINE; DOPAMINE 2 RECEPTOR; GLUTAMATE RECEPTOR AGONIST; GLUTAMATE RECEPTOR ANTAGONIST; METABOTROPIC RECEPTOR; QUINPIROLE; 2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE RECEPTOR; DOPAMINE RECEPTOR BLOCKING AGENT; DOPAMINE RECEPTOR STIMULATING AGENT; RACLOPRIDE; SALICYLAMIDE DERIVATIVE;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; ANIMAL; METABOLISM; MOTOR ACTIVITY; PHYSIOLOGY; RADIOASSAY; ROTATION; SPRAGUE DAWLEY RAT;

(R)-2,3,4,5-TETRAHYDRO-8-CHLORO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL; 2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ANIMALS; CORPUS STRIATUM; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; MALE; MOTOR ACTIVITY; QUINPIROLE; RACLOPRIDE; RADIOLIGAND ASSAY; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A2A; RECEPTORS, DOPAMINE D2; RECEPTORS, METABOTROPIC GLUTAMATE; RECEPTORS, PURINERGIC P1; ROTATION; SALICYLAMIDES;

EID: 0032587703     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(98)00154-3     Document Type: Article

References (55)

1. Albasanz J.L., Ros M., Martín M. Characterization of metabotropic glutamate receptors in rat C6 glioma cells. Eur. J. Pharmacol. 326:1997;85-91.
2. Albin R.L., Makowiec R.L., Hollingsworth Z.R., Dure L.S. IV, Penney J.B., Young A.B. Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience. 46:1992;35-48.
3. Attarian S., Amalric M. Microinfusion of the metabotropic glutamate agonist 1S-3R-1-aminocyclopentane-1,3-dicarboxylic acid into the nucleus accumbens induces dopamine-dependent locomotor activation inthe rat. Eur. J. Neurosci. 9:1997;809-816.
4. Calabresi P., Pisani A., Mercuri N.B., Bernardi G. The corticostriatal projection: from synaptic plasticity to dysfunctions of the basal ganglia. Trends Neurosci. 19:1996;19-24.
5. Catania M.V., de Socarraz J.H., Penney J.B. Jr., Young A.B. Metabotropic glutamate receptor heterogeneity in rat brain. Mol. Pharmacol. 45:1994;626-636.
6. Darlington C.L., Smith P.F. Metabotropic glutamate receptors in the guinea-pig medial vestibular nucleus in vitro. Neuroreport. 6:1995;1799-1802.
7. East S.J., Hill M.P., Brotchie J.M. Metabotropic glutamate receptor agonists inhibit endogenous glutamate release from rat striatal synaptosomes. Eur. J. Pharmacol. 277:1995;117-121.
8. Ferré S., von Euler G., Johansson B., Fredholm B.B., Fuxe K. Stimulation of high affinity adenosine A-2 receptors decreases the affinity of dopamine D-2 receptors in rat striatal membranes. Proc. Natl. Acad. Sci. USA. 88:1991;7238-7241.
9. Ferré S., Fuxe K., von Euler G., Johansson B, Fredholm B.B. Adenosine-dopamine interactions in the brain. Neuroscience. 51:1992;501-512.
10. Ferré S., O'Connor W.T., Fuxe K., Ungerstedt U. The striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain. J. Neurosci. 13:1993;5402-5406.
11. Ferré S., Fredholm B.B., Morelli M., Popoli P., Fuxe K. Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 20:1997;482-487.
12. 2 dopamine receptors in rat striatum. Mol. Brain Res. 14:1992;186-195.
13. 3H]N-propylnorapomorphine binding sites in striatal membranes. Eur. J. Pharmacol. 100:1984;127-130.
14. Garret B.E., Holtzman S.G. The effects of dopamine agonists on rotational behaviour in non-tolerant and caffeine-tolerant rats. Behav. Pharmacol. 6:1995;843-851.
15. Gotani H., Kuno M., Nakamura F., Matsuura S. Potentiation of excitatory postsynaptic potentials by a metabotropic glutamate receptor agonist (1S-3R-ACPD) in frog spinal motoneurons. Brain Res. 689:1995;281-288.
16. Greene C.C., Schwindt P.C., Crill W.E. Properties and ionic mechanisms of a metabotropic glutamate receptor-mediated slow afterdepolarization in neocortical neurons. J. Neurophysiol. 72:1994;693-704.
17. Herrera-Marschitz M., Foster C., Ungerstedt U. Rotational behaviour elicited by intracerebral injections of apomorphine and pergolide in 6-hydroxy-dopamine-lesioned rats. I: comparison between systemic and intrastriatal injections. Acta Physiol. Suppl. 125:1985;519-527.
18. Jane D.E., Pittaway K., Sunter D.C., Thomas N.K., Watkins J.C. New phenylglycine derivatives with potent and selective antagonist activity at presynaptic glutamate receptors in neonatal rat spinal cord. Neuropharmacology. 34:1995;851-856.
19. Joly C., Gomeza J., Brabet I., Curry K., Bokaert J., Pin J.-J. Molecular, functional, and pharmacological characterization of the metabotropic glutamate receptor type 5 splice variants: comparison with mGluR1. J. Neurosci. 15:1995;3970-3981.
20. Kaatz K.W., Albin R.L. Instrastriatal and intrasubthalamic stimulation of metabotropic glutamate receptors: a behavioural and FOS immunohistochemical study. Neuroscience. 66:1995;55-65.
21. 2 receptor-mediated modulation of contralateral rotation induced by metabotropic glutamate receptor activation. Eur. J. Pharmacol. 287:1995;115-120.
22. 14C]-2-deoxyglucose autoradiographic study. J. Neurosci. 17:1997;4415-4425.
23. Kehr J. Determination of glutamate and aspartate in microdialysis samples by reverse-phase column liquid chromatography with fluorescence and electrochemical detection. J. Chromat. B. 708:1998;27-38.
24. Kronthaler U.O., Schmidt W.J. 1S-3R-ACPD has cataleptogenic effects and reverses MK-801-, and less pronounced, d,l-amphetamine-induced locomotion. Eur. J. Pharmacol. 316:1996;129-136.
25. Manzoni O.J., Castillo P.E., Nicoll R.A. Pharmacology of metabotropic glutamate receptors at the mossy fiber synapses of the guinea pig hippocampus. Neuropharmacology. 34:1997;965-971.
26. Martin L.J., Blackstone C.D., Huganir R.L., Price D. Cellular localization of a metabotropic glutamate receptor in rat brain. Neuron. 9:1992;259-270.
27. 2 receptor interaction in globus pallidus. Synapse. 22:1996;132-138.
28. 2 receptors in unilaterally 6-hydroxydopamine-lesioned rats. Eur. J. Pharmacol. 251:1994;21-25.
29. Moroni F., Lombardi G., Thomsen C., Leonardi P., Attucci S., Peruginelli F., Albani Torregrossa S., Pellegrini-Giampietro D.E., Luneia R., Pellicciari R. Pharmacological characterization of 1-aminoindan-1,5-dicarboxilic acid, a potent mGluR1 antagonist. J. Pharmacol. Exp. Ther. 281:1997;721-729.
30. Nakanishi S. Molecular diversity of glutamate receptors and implications for brain function. Science. 258:1992;597-603.
31. Nicoletti F., Bruno V., Copani A., Casabona G., Knöpfel T. Metabotropic glutamate receptors: a new target for the therapy of neurodegenerative disorders? Trends Neurosci. 19:1996;267-271.
32. Okamoto T., Sekiyama N., Otsu M., Shimada Y., Sato A., Nakanishi S., Jingami H. Expression and purification of the extracellular ligand binding region of metabotropic glutamate receptor subtype 1. J. Biol. Chem. 273:1998;13089-13096.
33. Paul M.L., Graybiel A.M., David J.-C., Robertson H.A. D1-like and D-2 like dopamine receptors synergistically activate rotation and c-fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease. J. Neurosci. 12:1992;3729-3742.
34. Pellicciari R., Luneia R., Constantino G., Marinozzi M., Natalini B., Jakobsen P., Kanstrup A., Lombardi G., Moroni F., Thomsen C. 1-Aminoindan-1,5-dicarboxilic acid: a novel antagonist at phospholipase C-linked metabotropic glutamate receptors. J. Med. Chem. 38:1995;3717-3719.
35. Pin J.-P., Duvoisin R. The metabotropic glutamate receptors: structure and functions. Neuropharmacology. 34:1995;1-26.
36. 2 dopamine-dependent activation of Fos in the striopallidal pathway. Neuroscience. 68:1995;721-728.
37. 2A agonists: a potential new type of atypical antipsychotics. Neuropsychopharmacology. 17:1997;82-91.
38. Sacaan A.I., Monn J.A., Schoepp D.D. Intrastriatal injection of aselective metabotropic receptor agonist induces contralateral turning in the rat. J. Pharmacol. Exp. Ther. 259:1991;1366-1370.
39. Sacaan A.I., Bymaster F.P., Schoepp D.D. Metabotropic glutamate receptor activation produces extrapyramidal motor system activation that is mediated by striatal dopamine. J. Neurochem. 59:1992;245-251.
40. 2 receptor (RDC8) is expressed by enkephalin but not by substance P neurons: an in situ hybridization histochemistry study. J. Neurochem. 57:1991;1062-1067.
41. 3H]glutamate receptor binding in membranes. Neurosci. Lett. 145:1992;100-104.
42. Schoepp D.D., Conn P.J. Metabotropic glutamate receptors in brain function and pathology. Trends Pharmacol. Sci. 14:1993;13-20.
43. Schoepp D.D., Goldsworthy J., Johnson B.G., Salhoff C.R., Baker S.R. 3,5-Dihydroxyphenylglycine is a highly selective agonist for phophoinositide-linked metabotropic glutamate receptors in the rat hippocampus. J. Neurochem. 63:1995;769-772.
44. Shigemoto R., Nomura S., Ohishi H., Sugihara H., Nakanishi S., Mizuno N. Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain. Neurosci. Lett. 163:1993;53-57.
45. Tallaksen-Greene S.J., Kaatz K.W., Romano C., Albin R.L. Localization of mGluR1α-like immunoreactivity and mGluR5-like immunoreactivity in identified populations of striatal neurons. Brain Res. 780:1998;210-217.
46. Tanabe Y., Masu M., Ishii T., Shigemoto R., Nakanishi S. A family of metabotropic glutamate receptors. Neuron. 8:1992;169-179.
47. Tanabe Y., Nomura A., Masu M., Shigemoto R., Mizuno N., Nakanishi S. Signal transduction, pharmacological properties, and expression patterns of two rat metabotropic glutamate receptors, mGluR3 and mGluR4. J. Neurosci. 13:1993;1372-1378.
48. Testa C.M., Standaert D.G., Young A.B., Penney J.B. Jr. Metabotropic glutamate receptor mRNA expression in the basal ganglia of the rat. J. Neurosci. 14:1994;3005-3018.
49. Thompsen C., Mulvihill E.R., Haldeman B., Pickering D.S., Hampson D.R., Suzdak P.D. A pharmacological characterization of the mGluR1α subtype of the metabotropic glutamate receptor expressed in a cloned baby hamster kidney cell line. Brain Res. 619:1993;22-28.
50. Tizzano J.P., Griffey K.I., Schoepp D.D. Receptor subtypes linked to metabotropic glutamate receptor agonist-mediated limbic seizures in mice. Ann. NY Sci. 765:1995;230-235.
51. Ungerstedt U. Postsynaptic supersensitivity after 6-hydroxy-dopamine induced degeneration of the nigro-striatal dopamine system. Acta Physiol. Scand. Suppl. 367:1971;69-93.
52. Winder D.G., Conn P.J. Activation of metabotropic glutamate receptors increases cAMP accumulation in hippocampus by potentiating responses to endogenous adenosine. J. Neurosci. 13:1993;38-44.
53. Winder D.G., Conn P.J. Metabotropic glutamate receptor (mGluR)-mediated potentiation of cyclic AMP responses does not require phosphoinositide hydrolysis: Mediation by a group II-like mGluR. J. Neurochem. 64:1995;592-599.
54. 2 dopamine receptors in the basal ganglia of the rat: light and electron microscopy. Neuroscience. 65:1995;709-730.
55. Zoli M., Agnati L., Hedlund P., Li X., Ferré S., Fuxe K. Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol. Neurobiol. 7:1993;293-334.